We will see on Tuesday May 7, 2019 11:15 am to 11:30 am! It cannot be hidden and it will happen! CLINICAL TRIALS PLENARY SESSION Tuesday May 7, 2019 11:00 AM - 11:15 AM A Phase 3 Study of Isradipine as a Disease Modifying Agent in Patients with Early Parkinson’s disease (STEADY-PD III): Final Study Results Tanya Simuni MD